Chapters Transcript Video Salix Corporate Right now, millions of patients are suffering with GI disorders such as overt hepatic encephalopathy, irritable bowel syndrome, chronic idiopathic constipation, opioid induced constipation, val preparation and ulcerative colitis. At Salix, we have kept up with these unmet needs for more than 30 years by providing an industry leading portfolio of high quality products that address these conditions through our dedicated and innovative R and D team. We're also exploring potential new scientific breakthroughs and we remain committed to important healthcare provider investments in education, charitable grants and sponsorships. We will continue to invest millions of dollars in patient education and do our best to broaden access to selects medications because our mission to improve the care for G. I patients continues today. For us. There is no finish line. Yeah. Mhm. Published June 2, 2021 Created by
